Free Content Differential effects of contraction and PPAR agonists on the expression of fatty acid transporters in rat skeletal muscle

Authors: Benton, Carley R.; Koonen, Debby P. Y.1; Calles-Escandon, Jorge2; Tandon, Narendra N.3; Glatz, Jan F. C.1; Luiken, Joost J. F. P.; Heikkila, John J.4; Bonen, Arend5

Source: The Journal of Physiology, Volume 573, Number 1, May 2006 , pp. 199-210(12)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

You have access to the full text article on a website external to ingentaconnect.

Please click here to view this article on Wiley Online Library.

You may be required to register and activate access on Wiley Online Library before you can obtain the full text. If you have any queries please visit Wiley Online Library

Abstract:

We have examined over the course of a 1-week period the independent and combined effects of chronically increased muscle contraction and the peroxisome proliferator-activated receptor (PPAR)α and PPARγ activators, Wy 14,643 and rosiglitazone, on the expression and plasmalemmal content of the fatty acid transporters, FAT/CD36 and FABPpm, as well as on the rate of fatty acid transport. In resting muscle, the activation of either PPARα or PPARγ failed to induce the protein expression of FAT/CD36. PPARα activation also failed to induce the protein expression of FABPpm. In contrast, PPARγ activation induced the expression of FABPpm protein (40%; P < 0.05). Chronic muscle contraction increased the protein expression of FAT/CD36 (∼50%; P < 0.05), whereas FABPpm was slightly increased (12%; P < 0.05). Neither PPARα nor PPARγ activation altered the contraction-induced expression of FAT/CD36 or FABPpm. Changes in protein expression of FAT/CD36 or FABPpm, induced by either contractions or by administration of rosiglitazone, were largely attributable to increased transcription. The contraction-induced increments in FAT/CD36 were accompanied by parallel increments in plasmalemmal FAT/CD36 and in rates of fatty acid transport (P < 0.05). Up-regulation of FABPpm expression was, however, accompanied by a reduction in plasmalemmal FABPpm, which did not affect the rates of long chain fatty acid (LCFA) transport. These studies have shown that in skeletal muscle (i) neither PPARα nor PPARγ activation alters FAT/CD36 expression, (ii) PPARγ activation selectively up-regulates FABPpm expression and (iii) contraction-induced up-regulation of LCFA transport does not appear to occur via activation of either PPARα or PPARγ.

Document Type: Research article

DOI: http://dx.doi.org/10.1113/jphysiol.2006.106013

Affiliations: 1: Department of Molecular Genetics, Maastricht University, 6200-MD Maastricht, the Netherlands 2: Section of Endocrinology and Metabolism, Wake Forest University School of Medicine and Baptist Medical Center, Winston-Salem, NC 27157, USA 3: Thrombosis Research Laboratory, Otsuka Maryland Medicinal Laboratories, 9900 Medical Center Drive, Rockville, MD 20850, USA 4: Department of Biology, University of Waterloo, Waterloo, Ontario, Canada N2L 3G1 5: Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada N1G 2W1

Publication date: 2006-05-01

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page